These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22774644)

  • 21. Intestinal microbiota and overweight.
    Lyra A; Lahtinen S; Tiihonen K; Ouwehand AC
    Benef Microbes; 2010 Nov; 1(4):407-21. PubMed ID: 21831779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the contribution of obesity to the metabolic syndrome?
    Grundy SM
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):267-82, table of contents. PubMed ID: 15158519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview.
    Dulloo AG; Montani JP
    Obes Rev; 2012 Dec; 13 Suppl 2():1-5. PubMed ID: 23107254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of interactions between intestinal microbiota and intestinal macrophages on health.
    Nakata K; Yamamoto M; Inagawa H; Soma G
    Anticancer Res; 2013 Jul; 33(7):2849-53. PubMed ID: 23780969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urolithins are the main urinary microbial-derived phenolic metabolites discriminating a moderate consumption of nuts in free-living subjects with diagnosed metabolic syndrome.
    Tulipani S; Urpi-Sarda M; García-Villalba R; Rabassa M; López-Uriarte P; Bulló M; Jáuregui O; Tomás-Barberán F; Salas-Salvadó J; Espín JC; Andrés-Lacueva C
    J Agric Food Chem; 2012 Sep; 60(36):8930-40. PubMed ID: 22631214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.
    Schroen B; Heymans S
    Cardiovasc Res; 2012 Mar; 93(4):605-13. PubMed ID: 21994347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the gut in visceral fat inflammation and metabolic disorders.
    Lam YY; Mitchell AJ; Holmes AJ; Denyer GS; Gummesson A; Caterson ID; Hunt NH; Storlien LH
    Obesity (Silver Spring); 2011 Nov; 19(11):2113-20. PubMed ID: 21881620
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between gut microbiota and weight gain in humans.
    Angelakis E; Armougom F; Million M; Raoult D
    Future Microbiol; 2012 Jan; 7(1):91-109. PubMed ID: 22191449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, metabolic syndrome, and microbiota: multiple interactions.
    Tilg H
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; Leroith D; Karnieli E
    Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota and obesity.
    Scarpellini E; Campanale M; Leone D; Purchiaroni F; Vitale G; Lauritano EC; Gasbarrini A
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S53-6. PubMed ID: 20865475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis.
    Rojas-Rodríguez J; Escobar-Linares LE; Garcia-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Zamora-Ustaran A
    Med Hypotheses; 2007; 69(4):860-8. PubMed ID: 17368954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbial metabolome: modulation of cancer risk in obese individuals.
    Russell WR; Duncan SH; Flint HJ
    Proc Nutr Soc; 2013 Feb; 72(1):178-88. PubMed ID: 23174203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and hypertension as two anthropometric predictors for metabolic syndrome.
    Wenying Y; Zhaojun Y
    Horm Metab Res; 2006 Jul; 38(7):469-70. PubMed ID: 16933185
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
    Kang YS; Cha JJ; Hyun YY; Cha DR
    Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiology. Girth and the gut (bacteria).
    Pennisi E
    Science; 2011 Apr; 332(6025):32-3. PubMed ID: 21454769
    [No Abstract]   [Full Text] [Related]  

  • 40. Obesity: genes, brain, gut, and environment.
    Das UN
    Nutrition; 2010 May; 26(5):459-73. PubMed ID: 20022465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.